Structural Biology of Multi-Domain Nuclear Receptor Complexes
Structural Biology of Multi-Domain Nuclear Receptor Complexes
批准号:
9159659
负责人:
FRAYDOON RASTINEJAD
金额:
$38.27万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-01 至 2021-02-28
关键词:
ArchitectureBindingBiochemicalBiological AssayCellsCommunicationComplexCouplingCrystallizationDNADNA BindingDNA Binding DomainDevelopmental ProcessDietary FatsDirect RepeatsDrug PrescriptionsElementsEmbryonic DevelopmentFamilyFatty AcidsFertilityGene ExpressionGenetic TranscriptionHemeHumanIndividualLeadLearningLengthLigand BindingLigand Binding DomainLigandsLinkMediatingMetabolismMolecularN-terminalNuclear ReceptorsPPAR gammaPathway interactionsPeptidesPhysiologicalProgesterone ReceptorsPropertyRXRReportingReproductive ProcessResponse ElementsRetinoic Acid ReceptorRetinoic Acid Response ElementRetinoidsSeriesSignal TransductionSiteSteroid ReceptorsSteroidsStructureSurfaceX ray diffraction analysisX-Ray Diffractionbaselipid metabolismlipophilicitymonomerpolypeptideprogesterone receptor Aprogramsprotein complexreceptorreceptor bindingreceptor functionresponsesmall moleculesteroid hormonestructural biologytranscription factor
中文摘要
项目摘要
包括类固醇激素、类维生素A、脂肪酸和膳食脂质在内的亲脂分子控制生殖,
通过直接结合和调节核受体的活性来调节发育和代谢过程
(NRs)。NR与DNA结合并调节基因程序的表达,这些基因程序导致对DNA的生理反应。
它们的小分子配体在过去的几十年里,结构研究主要集中在
配体结合结构域(LBD)或DNA结合结构域(DBD)的NR,但无法揭示如何
多域体系结构被集成在四级结构中。为了了解身体和功能
不同受体结构域的偶联,我们一直在进行涉及全长的X射线衍射研究
和多结构域核受体复合物,其在功能上揭示与DNA,配体,
和辅调节肽。我们以前的研究表明,PPARγ-RXRα的DBDs和LBD
异二聚体和HNF-4α同二聚体通过结构域高度界面排列物理连接
表面,其中一些是DNA依赖的。我们现在建议大大拓宽我们对
核受体家族中的结构域-结构域连接和变构通讯。我们将获得
三个新的NR复合物的晶体结构,包括视黄酸受体(RAR)异二聚体
与维甲酸X受体(RXR)、孕酮受体(PR)同型二聚体和单体Rev-Erbβ
受体的这些不同的NR还辨别由正向重复、反向重复和反向重复组成的不同的反应元件。
重复和单个半位点,因此,与
先前在PPARγ-RXRα或HNF-4α中观察到。我们还建议进行一系列补充性的
生物化学和基于细胞的功能研究,以探测和定量的机制基础,
结构域变构信号在这些受体复合物中的传播。
英文摘要
PROJECT SUMMARY
Lipophilic molecules including steroid hormones, retinoids, fatty acids, and dietary lipids control reproductive,
developmental and metabolic processes by directly binding and modulating the activities of nuclear receptors
(NRs). NRs bind to DNA and regulate the expression of gene programs that lead to physiological responses to
their small-molecule ligands. Structural studies over the past few decades have focused primarily on just the
ligand binding domains (LBDs) or DNA-binding domains (DBDs) of NRs, but were unable to reveal how the
multi-domain architectures are integrated in a quaternary structure. To understand the physical and functional
coupling of different receptor domains, we have been conducting X-ray diffraction studies involving full-length
and multi-domain nuclear receptor complexes in their functionally revealing complexes bound to DNA, ligands,
and coregulator peptides. Our previous studies revealed that DBDs and LBDs of the PPARγ-RXRα
heterodimer and HNF-4α homodimer are physically linked through a highly interfaced arrangement of domain
surfaces, some of which are DNA-dependent. We now propose to considerably broaden our understanding of
the domain-domain connections and allosteric communications in the nuclear receptor family. We will obtain
the crystal structures of three new NR complexes that include the Retinoic-Acid Receptor (RAR) heterodimer
with Retinoid X Receptor (RXR), the progesterone receptor (PR) homodimer, and the monomeric Rev-Erbβ
receptor. These differing NRs also discern distinct response elements consisting of direct repeats, inverted
repeats, and single half-sites, thus, distinctive domain-domain interfaces are anticipated as compared to
previously seen in PPARγ-RXRα or HNF-4α. We further propose to conduct a series of complementary
biochemical and cell-based functional studies to probe and quantitate the mechanistic underpinning of inter-
domain allosteric signal propagation in these receptor complexes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of Hypoxia-Inducible Factor-2alpha Activators for Chronic Kidney Disease Anemia
-
批准号:9906953
-
项目类别:
-
资助金额:$35.15万
-
财政年份:2018
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Identification of Hypoxia-Inducible Factor-2alpha Activators for Chronic Kidney Disease Anemia
-
批准号:9577222
-
项目类别:
-
资助金额:$11.26万
-
财政年份:2018
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Molecular Characterization of Mammalian bHLH-PAS Transcription Factors
-
批准号:9324331
-
项目类别:
-
资助金额:$38.51万
-
财政年份:2016
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Molecular Characterization of Mammalian bHLH-PAS Transcription Factors
-
批准号:9113818
-
项目类别:
-
资助金额:$38.51万
-
财政年份:2016
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Identification of Rev-Erb alpha/beta nuclear receptor modulators
-
批准号:8671893
-
项目类别:
-
资助金额:$52.98万
-
财政年份:2014
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Identification of Allsoteric Ligands for Hepatic Nuclear Factor 4-alpha
-
批准号:8421932
-
项目类别:
-
资助金额:$52.79万
-
财政年份:2012
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Identification of Allsoteric Ligands for Hepatic Nuclear Factor 4-alpha
-
批准号:8775220
-
项目类别:
-
资助金额:$55.78万
-
财政年份:2012
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Structural Characterization of Metabolic Gene Regulators
-
批准号:8728842
-
项目类别:
-
资助金额:$42.41万
-
财政年份:2011
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Structural Characterization of Metabolic Gene Regulators
-
批准号:8339923
-
项目类别:
-
资助金额:$42.41万
-
财政年份:2011
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Structural Characterization of Metabolic Gene Regulators
-
批准号:8538964
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2011
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
Structural Characterization of Metabolic Gene Regulators
-
批准号:8222237
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2011
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
FXR interactions with ligands and coregulators
-
批准号:6919236
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2004
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
FXR interactions with ligands and coregulators
-
批准号:7270665
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2004
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
FXR interactions with ligands and coregulators
-
批准号:6825536
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2004
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
FXR interactions with ligands and coregulators
-
批准号:7104379
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2004
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
MOLECULAR RECOGNITION IN STEROID SIGNALING
-
批准号:6381515
-
项目类别:
-
资助金额:$26.85万
-
财政年份:1999
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
MOLECULAR RECOGNITION IN STEROID SIGNALING
-
批准号:2827954
-
项目类别:
-
资助金额:$25.3万
-
财政年份:1999
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
MOLECULAR RECOGNITION IN STEROID SIGNALING
-
批准号:6517587
-
项目类别:
-
资助金额:$27.65万
-
财政年份:1999
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
MOLECULAR RECOGNITION IN STEROID SIGNALING
-
批准号:6177454
-
项目类别:
-
资助金额:$26.06万
-
财政年份:1999
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
PROGESTERONE RECEPTOR DNA BINDING COMPLEX DETERMINED BY MAD
-
批准号:6281297
-
项目类别:
-
资助金额:$2.48万
-
财政年份:1998
-
负责人:FRAYDOON RASTINEJAD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: